Orrick represented Fisker on the deal. Fisker has closed on $340 million in unsecured convertible notes with an original issue discount of 12 percent, resulting in...
You must be a Standard 1 Year member to access this content.
Orrick advised BioAtla on the deal. Clinical-stage biotechnology company BioAtla, Inc. (Nasdaq: BCAB) announced the sale of 9,745,128 shares of its common stock at a price of...
You must be a Standard 1 Year member to access this content.
Orrick advised Fisker on the deal. Fisker (NYSE: FSR) announced the establishment of its at-the-market equity program with J.P. Morgan Securities and Cowen and Company as...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP advised Fortinet on the deal. Fortinet (Nasdaq: FTNT), a global leader in broad, integrated and automated cybersecurity solutions, announced its underwritten, registered public...
You must be a Standard 1 Year member to access this content.
